BioMedWire Stocks

Helmets Will Not Protect Individuals Against Concussions, Expert Says

Concussions are a type of brain injury that occurs when the head is struck hard enough that the brain smacks against the skull and is damaged. Such injuries can also happen when the body is shaken violently enough to cause the brain to move around in the skull, such as during whiplash.

As with most head injuries, concussions can have major consequences if they are severe or not treated early enough. Over the long term, some patients may develop a condition called post-concussion syndrome, which is characterized by dizziness, headaches and problems with memory and concentration.

Aside from car accidents, concussions are overwhelmingly common in sports such as football and boxing, which involve a degree of physicality. According to neuroscientist professor Alan Pearce, the risk of concussive injuries in such sports has been increased by the myth that helmets are capable of protecting the wearer from these injuries.

Speaking in a recent episode of the investigative series podcast Head Noise, Pearce stated that helmets do not prevent players from sustaining concussions. Pearce told host James Graham that helmets weren’t designed to protect the brain from concussive forces. They are meant to protect the skull from lacerations and fractures, he said, but they do not have the ability to absorb all the force generated by an impact.

This means that while a helmet will prevent a wearer from sustaining broken or lacerated skull bones, it cannot prevent the brain from slamming against the inside of the skull. Given that brain tissue is delicate enough to squish through fingers, even the slightest movement can stretch the brain, placing brain cells under tension and causing them to tear against each other.

Furthermore, he explained that since the white matter and gray matter of the brain are of different densities, any impact actually causes the brain to move at two different speeds, resulting in even more strain and damage. Helmets aren’t capable of absorbing enough impact force to prevent concussions or even microdamage from occurring, Pearce said, be they hard-shell or soft-shell helmets.

In fact, helmets may actually increase the risk of concussion because they can give players a false sense of security and cause them to lower their guard, Pearce said. Furthermore, the presence of a helmet may make opposing players think they can play a little harder or sloppier because the other team is protected by helmets.

Generally, athletes wearing helmets are more likely to engage in riskier behavior than those without. When it comes to addressing the concussion crisis in sports such as the NFL, helmets are part of the problem not the solution.

At the moment, no drugs are specifically approved for concussion treatment. Companies such as Odyssey Health Inc. (OTC: ODYY) are focused on changing that through their clinical development programs, and if all goes according to plan, a remedy may soon be available to help concussion patients avoid experiencing complications that result from an untreated concussion.

NOTE TO INVESTORS: The latest news and updates relating to Odyssey Health Inc. (OTC: ODYY) are available in the company’s newsroom at https://ibn.fm/ODYY

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Soligenix Inc. (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma

Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the…

5 hours ago

Sapu Nano Reveals the Initial In-Human Clinical Trial of Sapu-003, Intravenous Everolimus (Afinitor(R)) at Australian Translational Breast Cancer Symposium

The company revealed the trial at the Australia Translational Breast Cancer Research Symposium (“ATBCR”) Sapu-003…

5 hours ago

How Rural Health Care is Being Impacted by the Federal Funding Landscape

Approximately 20% of people in the U.S. live in a rural area, and they face…

3 days ago

$37.5M Grant Announced to Boost Management of Infectious Diseases in the US

On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant…

4 days ago

What Patients Need to Know About the Remission Rate of Glioblastomas

Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer.…

6 days ago

Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability

Thermostable vaccine technology is considered a significant unmet need in epidemic preparedness. Soligenix has been…

6 days ago